IRD Reports $43.6M Cash, Advances LCA5, BEST1 Gene Therapies, Expected Runway into 2029
Opus Genetics, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $4.12
-17% in 7d after detection
Post-detection moves
1h
—
1d
-2.9%
3d
-7.3%
7d
-17%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS